Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Chicago, IL
NPI: 1164481412Primary Practice Location
ADVOCATE ILLINOIS MASONIC MEDICAL CENTER
836 W Wellington Ave, Chicago, IL
Primary Employer
Advocate Medical Group
advocatehealth.com
HQ Phone
Get M.D. Sigrun's Phone Numberphone_androidMobile
Get M.D. Sigrun's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 194 | 397 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 121 | 149 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 61 | 105 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 35 | 61 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 30 | 49 |
Authors: Brendan Curti, Kim Margolin, Gregory Daniels, Lynn Feun, Robert Andtbacka
Journal: J Immunother Cancer
Authors: Nikhil Khushalani, Robert Mc Williams, Hussein Tawbi, David Mcdermott
Journal: Immunotherapy
Publication Date: 2023-11-08
Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.
Authors: Shari Damast, David Kushner
Publication Date: 2017-12-12
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab
Lead Sponsor: Wake Forest University Health Sciences
Intervention / Treatment: OTHER: Screening
